China’s new cancer drug Toripalimab is approved in the US but will cost 30 times more - eviltoast
US$280 in China, US$8,892 in the US: new Chinese cancer drug gets FDA approval
www.scmp.com
Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
  • barrbaric [he/him]@hexbear.netEnglish
    15·
    1 year ago

    Isn’t 30x what everyone else pays actually kind of low for drugs? I guess it’s because the base price is already actually kinda high.